Home BUSINESS News FDA Approves GSK’s RSV Vaccine for Older Adults

FDA Approves GSK’s RSV Vaccine for Older Adults

0
FDA Approves GSK’s RSV Vaccine for Older Adults

[ad_1]

Approval of respiratory syncytial virus vaccine is a first for people 60 years and older, company says

[ad_2]

Source link